Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 3,180 $ 2,772
Restricted cash 250 600
Accounts receivable, net of allowance for doubtful accounts of $72 and $275, respectively 6,518 8,028
Other current assets 3,135 2,722
Total current assets 13,083 14,122
Property and equipment, net 6,484 7,349
Other intangible assets, net 8,014 11,351
Goodwill 8,433 8,433
Operating lease right of use assets, net 3,989 4,384
Other long-term assets 304 42
Total assets 40,307 45,681
Current liabilities:    
Accounts payable 2,427 4,511
Accrued salary and bonus 2,728 3,161
Notes payable - related parties 7,872
Other accrued expenses 9,043 9,795
Current liabilities from discontinued operations 766 766
Total current liabilities 22,836 18,233
Contingent consideration, net of current portion 1,663 1,818
Operating lease liabilities, net of current portion 3,152 3,540
Other long-term liabilities 4,768 4,637
Total liabilities 32,419 28,228
Commitments and contingencies (Note 8)  
Preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 Series B issued and outstanding 46,536 46,536
Stockholders’ deficit:    
Common stock, $.01 par value; 100,000,000 shares authorized; 4,194,111 and 4,075,257 shares issued, respectively; 4,174,447 and 4,055,593 shares outstanding, respectively 403 402
Additional paid-in capital 186,052 184,404
Accumulated deficit (223,330) (212,116)
Treasury stock, at cost (19,664 and 19,664 shares, respectively) (1,773) (1,773)
Total stockholders’ deficit (38,648) (29,083)
Total liabilities, preferred stock and stockholders’ deficit $ 40,307 $ 45,681